0Studies tracked
0Claims cite
0Videos use
Average study score: 73/100
Bibliography
Studies by this author
1 study attributed to Trenton T. Ross on the platform. Click a card to read the full analysis.
Study
ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials
This study evaluates whether inhibiting ACC1/2 and/or DGAT2 enzymes can reduce liver fat in adults with non-alcoholic fatty liver disease (NAFLD).